Taltirelin

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597825

CAS#: 103300-74-9

Description: Taltirelin is a thyrotropin-releasing hormone analog. Taltirelin alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.

Chemical Structure

img
Taltirelin
CAS# 103300-74-9
Instruction

Theoretical Analysis

MedKoo Cat#: 597825
Name: Taltirelin
CAS#: 103300-74-9
Chemical Formula: C17H23N7O5
Exact Mass: 405.18
Molecular Weight: 405.410
Elemental Analysis: C, 50.36; H, 5.72; N, 24.18; O, 19.73

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Taltirelin; TA 0910; TA-0910; TA0910; CCRIS 8513;

IUPAC/Chemical Name: (S)-N-((S)-1-((S)-2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide

InChi Key: LQZAIAZUDWIVPM-SRVKXCTJSA-N

InChi Code: InChI=1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1

SMILES Code: O=C(N)[C@H]1N(C([C@H](CC2=CNC=N2)NC([C@H](CC(N3C)=O)NC3=O)=O)=O)CCC1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 405.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Eto K, Kim SK, Nabekura J, Ishibashi H. Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain. Brain Res. 2011 Sep 26;1414:50-7. doi: 10.1016/j.brainres.2011.07.065. Epub 2011 Aug 6. PubMed PMID: 21872219.

2: Ijiro T, Nakamura K, Ogata M, Inada H, Kiguchi S, Maruyama K, Nabekura J, Kobayashi M, Ishibashi H. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system. Eur J Pharmacol. 2015 Aug 15;761:413-22. doi: 10.1016/j.ejphar.2015.05.047. Epub 2015 Jul 2. PubMed PMID: 26142830.

3: Thirunarayanan N, Raaka BM, Gershengorn MC. Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor. Front Endocrinol (Lausanne). 2012 Oct 9;3:120. doi: 10.3389/fendo.2012.00120. eCollection 2012. PubMed PMID: 23087672; PubMed Central PMCID: PMC3466466.

4: Thirunarayanan N, Nir EA, Raaka BM, Gershengorn MC. Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice. Neuropsychopharmacology. 2013 May;38(6):950-6. doi: 10.1038/npp.2012.256. Epub 2012 Dec 11. PubMed PMID: 23303050; PubMed Central PMCID: PMC3629383.

5: Asai H, Watanabe Y, Yamauchi-Kohno R, Doi O. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate. J Recept Signal Transduct Res. 2011 Dec;31(6):416-22. doi: 10.3109/10799893.2011.625427. Epub 2011 Nov 1. PubMed PMID: 22044177.

6: Yamamura M, Suzuki M, Matsumoto K. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)]. Nihon Yakurigaku Zasshi. 1997 Oct;110 Suppl 1:33P-38P. Review. Japanese. PubMed PMID: 9503402.

7: Tanabe M, Tokuda Y, Takasu K, Ono K, Honda M, Ono H. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems. Br J Pharmacol. 2007 Feb;150(4):403-14. Epub 2007 Jan 15. PubMed PMID: 17220907; PubMed Central PMCID: PMC2189720.

8: Fukuchi I, Asahi T, Kawashima K, Kawashima Y, Yamamura M, Matsuoka Y, Kinoshita K. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. Arzneimittelforschung. 1998 Apr;48(4):353-9. PubMed PMID: 9608876.

9: Asai H, Asahi T, Yamamura M, Yamauchi-Kohno R, Saito A. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Pharmacol Biochem Behav. 2005 Dec;82(4):646-51. Epub 2005 Dec 20. PubMed PMID: 16368129.

10: Imahie H, Kobayashi T, Imado N, Inui T, Ariyuki F, Asano Y. [Reproductive and developmental toxicity studies of taltirelin hydrate (1) fertility study in rats by oral administration]. J Toxicol Sci. 1997 Nov;22 Suppl 2:371-9. Japanese. PubMed PMID: 9430095.

11: Brown W. Taltirelin. Tanabe Seiyaku. IDrugs. 1999 Oct;2(10):1059-68. PubMed PMID: 16118715.

12: Imahie H, Kobayashi T, Nishida A, Imado N, Asano Y. [Reproductive and developmental toxicity studies of taltirelin hydrate (2) teratogenicity study in rats by oral administration]. J Toxicol Sci. 1997 Nov;22 Suppl 2:381-94. Japanese. PubMed PMID: 9430096.

13: Horimoto S, Mayumi T, Tagawa K, Yamakita H, Yoshikawa M. Determination of taltirelin, a new stable thyrotropin-releasing hormone analogue, in human plasma by high-performance liquid chromatography turbo-ionspray ionization tandem mass spectrometry. J Pharm Biomed Anal. 2002 Nov 7;30(4):1361-9. PubMed PMID: 12408927.

14: Urayama A, Yamada S, Kimura R, Zhang J, Watanabe Y. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice. Life Sci. 2002 Dec 20;72(4-5):601-7. PubMed PMID: 12467901.

15: Imahie H, Nishida A, Imado N, Asano Y. [Reproductive and developmental toxicity studies of taltirelin hydrate (3) teratogenicity study in rabbits by oral administration]. J Toxicol Sci. 1997 Nov;22 Suppl 2:395-403. Japanese. PubMed PMID: 9430097.

16: Nie C, Yang D, Liu N, Dong D, Xu J, Zhang J. Thyrotropin-releasing hormone and its analogs accelerate wound healing. J Surg Res. 2014 Jun 15;189(2):359-65. doi: 10.1016/j.jss.2014.03.004. Epub 2014 Mar 11. PubMed PMID: 24713470.

17: Urayama A, Yamada S, Hirano K, Deguchi Y, Kimura R. Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues. Life Sci. 2001 Dec 28;70(6):647-57. PubMed PMID: 11833715.

18: Imahie H, Koguchi A, Kobayashi T, Asano Y. [Reproductive and developmental toxicity studies of taltirelin hydrate (4) perinatal and postnatal study in rats by oral administration]. J Toxicol Sci. 1997 Nov;22 Suppl 2:405-17. Japanese. PubMed PMID: 9430098.

19: Asai H, Kinoshita K, Yamamura M, Matsuoka Y. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats. Jpn J Pharmacol. 1999 Mar;79(3):313-7. PubMed PMID: 10230859.

20: Yamamura T, Nishimura T, Kuwamura Y, Inui T, Aughton P, Kawai Y. Oncogenicity studies of taltirelin tetrahydrate (TA-0910) by oral (GAVAGE) administration in CD-1 mice and CD rats. J Toxicol Sci. 1997 Nov;22 Suppl 2:419-30. PubMed PMID: 9430099.